Top 20 Companies in Global Dermatology Excimer Laser Market (2025–2035): Competitive Analysis & Forecast
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, the Global Dermatology excimer laser Market Size is projected to grow from USD 593.7 Billion in 2024 to USD 997.5 Billion by 2035, at a CAGR of 4.83% during the forecast period 2025–2035. The Global Dermatology excimer laser Market is driven by the rising incidence of chronic skin conditions and an increasing shift toward targeted, non-invasive phototherapy.
Introduction
The Global Dermatology Excimer Laser market is characterized by the increasing adoption of specialized phototherapy systems that utilize a noble gas-halide mixture to generate concentrated ultraviolet light at a specific 308-nm wavelength. Unlike traditional broadband ultraviolet treatments, these excimer systems are defined by their ability to deliver high-intensity radiation exclusively to localized skin lesions, which effectively spares surrounding healthy tissue from unnecessary exposure. This targeted approach is particularly vital for treating chronic autoimmune conditions such as vitiligo and psoriasis, where the laser induces T-cell apoptosis to stabilize disease progression. Recent market innovations focus on enhancing clinical efficiency through precision immune modulation. Emerging trends include the integration of 308-nm excimer lasers with novel pharmacological agents like JAK inhibitors and platelet-rich plasma to significantly improve repigmentation rates in difficult-to-treat areas. Furthermore, the development of monochromatic excimer lamps and portable LED-based excimer devices has expanded the therapeutic landscape, offering lighter and more cost-effective alternatives to stationary gas lasers. The primary driving factors for this market include the rising global prevalence of inflammatory skin disorders and a growing patient preference for non-invasive procedures with rapid onset results. Additionally, the ability of excimer technology to reduce cumulative radiation doses and lower long-term carcinogenic risks compared to older phototherapy methods continues to propel its integration into modern dermatological practices.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Dermatology excimer laser Market.
Dermatology Excimer Laser Market Size & Statistics
- The Market Size for Dermatology excimer laser Was Estimated to be worth USD 593.7 Billion in 2024.
- The Market is Going to Expand at a CAGR of 4.83% between 2025 and 2035.
- The Global Dermatology excimer laser Market Size is anticipated to reach USD 997.5 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Dermatology excimer laser Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Dermatology excimer laser Market.

Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Dermatology excimer laser market. Asia Pacific is expected to grow fastest due to a massive patient pool and increasing healthcare expenditure across emerging economies. Rapid urbanization and a burgeoning middle class in countries like China and India are driving a surge in elective aesthetic procedures and advanced medical treatments. Furthermore, the expansion of local manufacturing capabilities and a rising emphasis on medical tourism for dermatological care are accelerating the integration of excimer laser technology throughout the region
North America is expected to generate the highest demand during the forecast period in the Dermatology excimer laser market. North America is expected to generate the highest demand due to an advanced healthcare ecosystem and a high concentration of specialized aesthetic clinics. The region's leadership is reinforced by the presence of major industry innovators and a regulatory environment that favors early adoption of cutting-edge phototherapy technologies. Additionally, high patient awareness regarding skin health and favorable reimbursement frameworks for chronic conditions like psoriasis significantly sustain the consistent demand for these high-end laser systems.
Ready to lead the Dermatology excimer laser Market ?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the Dermatology Excimer Laser Market
- AI-Driven Personalized Treatment Planning
- Integration with JAK Inhibitor Therapy
- Rise of Handheld and Portable Devices
- MED-Guided Dosing Protocols
- Development of Monochromatic Excimer Lamps
- Pediatric Dermatology Adoption
- Growth in Medical Tourism for Phototherapy
- Focus on Reducing Carcinogenic Risk
- Combined Protocols with Platelet-Rich Plasma (PRP)
- Adoption in Ambulatory Surgery Centers (ASCs)
- Integration with JAK Inhibitor Therapy
A significant clinical trend is the dual-action approach, where 308-nm excimer lasers are used alongside Janus kinase (JAK) inhibitors. Research shows that combining localized phototherapy with these systemic or topical drugs accelerates repigmentation in vitiligo and plaque clearance in psoriasis. This synergy addresses the limitations of monotherapy, particularly in refractory or difficult-to-treat anatomical sites.
- MED- Guided Dosing Protocols
Clinicians are increasingly adopting Minimal Erythema Dose (MED) testing as a standard prerequisite for laser therapy. By determining a patient's specific sensitivity to UVB light before starting treatment, doctors can deliver higher, more effective fluences without the risk of burning healthy skin. This precision-based dosing is proven to shorten the overall course of therapy.
- Development of Monochromatic Excimer Lamps
The market is seeing a surge in monochromatic excimer lamps as a cost-effective alternative to traditional gas lasers. These lamps provide a similar 308-nm wavelength but typically have lower maintenance costs and a longer lifespan. This trend is making targeted phototherapy accessible to a wider range of mid-tier healthcare facilities and private practices.
- Focus on Reducing Carcinogenic Risk
A major selling point and trend in marketing is the safety profile of excimer lasers compared to traditional PUVA (Psoralen + UVA) therapy. Because the laser limits the cumulative UV dose to only the affected lesions, the long-term risk of skin cancer is significantly lower. This safety-first narrative is a powerful driver in patient preference and clinical adoption.
- Combined Protocols with Platelet-Rich-Plasma (PRP)
In the pursuit of faster results for vitiligo, researchers are enlisting triple combination therapies: fractional CO2 lasers, 308-nm excimer light, and PRP injections. This regenerative medicine trend aims to stimulate melanocyte migration more aggressively, providing a multi-layered approach to restoring skin pigment in stubborn cases.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Dermatology excimer laser market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 20 Companies Leading the Dermatology Excimer Laser Market
- STRATA Skin Sciences
- Ra Medical Systems
- The Daavlin Company
- Schenzen GSD Tech Co
- Kernel Medical Equipment
- Lumenis Be Ltd
- Fotona
- Beijing Sincoheren S&T Development Co Ltd
- Candela Medical
- Cynosure
- Cutera
- Lutronic Corporation
- Quanta System
- Bausch + Lomb
- Sciton
- DEKA Research & Development
- Asclepion Laser Technologies
- Syneron Medical
- InMode
- Hologic
- STRATA Skin Sciences
Headquarters: Horsham, Pennsylvania, USA
STRATA Skin Sciences, active in over 40 countries, is a specialized medical technology company that has carved out a unique niche by focusing almost exclusively on the therapeutic dermatology market. The company is best known for its XTRAC excimer laser, which has become a gold standard for treating localized inflammatory skin conditions like psoriasis and vitiligo. Unlike traditional manufacturers, STRATA operate a distinct partnership business model, where they provide the laser hardware to clinics and generate revenue through a fee-per-treatment system. This ensures that their technology is accessible to a wide range of dermatology practices without the burden of high upfront capital costs.
- Alma Lasers
Headquarters: Caesarea, Israel
Alma Lasers, active in over 100 countries, is a subsidiary of Sisram Medical and is a global powerhouse in the energy-based medical device sector. While they are renowned for aesthetic solutions like hair removal and skin tightening, their contribution to the dermatology excimer market is significant through their specialized 308-nm excimer technology. Alma’s approach to the market centers on Total Care, providing clinicians with versatile platforms that can address a multitude of indications. Their excimer systems are designed to be user-friendly, featuring advanced cooling mechanisms and ergonomic handpieces that allow for precise targeting of small or sensitive anatomical areas. The company’s market activity is characterized by heavy investment in research and development, often collaborating with leading academic institutions to validate the efficacy of their monochromatic light systems
.
- The Daavlin Company
Headquarters: Bryan, Ohio, USA
The Daavlin Company, active in more than 30 countries, with a strong focus on North America and emerging markets in Asia and South America. Daavlin specializes in the science of light for chronic skin disease management. They are a critical player in the excimer market due to their development of targeted phototherapy units that bridge the gap between large-scale UVB booths and precision laser systems. Their activity in the market is largely mission driven, focusing on improving the quality of life for patients suffering from psoriasis, vitiligo, and eczema through accessible technology. Daavlin’s portfolio includes advanced 308-nm excimer lamps, which provide many of the clinical benefits of a laser, such as localized treatment and high intensity, at a more manageable price point for smaller clinics.
- Lumenis Be Ltd
Headquarters: Yokneam, Israel
Lumenis Be Ltd, active in over 100 countries, with significant operations in the US, Europe, Japan, and China. Lumenis is widely regarded as one of the pioneers of the medical laser industry, holding hundreds of patents and numerous regulatory clearances. Their involvement in the dermatology excimer market is part of a broader strategy to lead in minimally invasive clinical solutions. Lumenis is known for its high-performance engineering, often setting the technical benchmarks for energy-based devices. Their activity in the excimer sector is marked by the integration of laser technology with sophisticated digital interfaces, allowing for unprecedented control over beam delivery and energy density.
- Shenzhen GSD Tech Co, Ltd
Headquarters: Shenzhen, China
Shenzhen GSD Tech Co Ltd, active in over 60 countries, is a leading representative of the rapidly growing Chinese medical device industry. They have gained international recognition for their Eximal series, a line of 308-nm excimer light systems that have become a staple in many dermatology clinics across Asia and beyond. GSD’s activity in the market is defined by a balance of high-tech innovation and cost-effectiveness. By streamlining the manufacturing process and focusing on the core physics of xenon-chloride gas lasers, GSD has made targeted phototherapy more accessible to a global audience. The Eximal Elite and other portable units from GSD are designed for high patient throughput, featuring large spot sizes and rapid pulse rates. Their technology is particularly popular in regions with high vitiligo prevalence, where large numbers of patients require regular, localized treatment. GSD was one of the first Chinese manufacturers to secure both US FDA clearance and the European Medical CE mark, signalling their commitment to international quality standards. Their market strategy involves heavy participation in global trade exhibitions and a focus on smart features, such as touchscreen interfaces and automated dosing protocols that simplify the treatment process for clinicians.
Are you ready to discover more about the Dermatology excimer laser market?
The report provides an in-depth analysis of the leading companies operating in the global Dermatology excimer laser market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Alma Lasers
- Ra Medical Systems
- The Daavlin Company
- Kernel Medical Equipment
- Lumenis Be Ltd
- Fotona
- Beijing Sincoheren S&T Development Co Ltd
- Candela Medical
- Others.
Conclusion
The global dermatology excimer laser market is witnessing significant growth, driven by the rising incidence of chronic skin conditions and an increasing shift toward targeted, non-invasive phototherapy. Excimer lasers provide precise, high-intensity 308-nm radiation that effectively stabilizes autoimmune disorders like vitiligo and psoriasis while minimizing exposure to healthy tissue. Innovations in device portability, AI-integrated dosing, and combination treatments with novel pharmaceuticals further enhance therapeutic efficacy and patient safety. Leading companies such as STRATA Skin Sciences, Alma Lasers, The Daavlin Company, Lumenis Be Ltd., and Shenzhen GSD Tech are expanding their global footprints and driving technological advancements. Overall, excimer laser systems play a vital role in the evolution of precision dermatology, offering a safer, more localized alternative to traditional ultraviolet treatments and significantly improving the long-term management of inflammatory skin diseases across the globe.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
Contact Us:
Company Name: Decision Advisors
Email: sales@sphericalinsights.com
Phone: +1 303 800 4326 (US)
Need help to buy this report?